Symbols

SOLV

Solventum·NYSE

--(--)

SOLV fundamentals

SOLV Q4 2025 Earnings

Solventum (SOLV) released its earnings on Feb 26, 2026: revenue was 2.00B (YoY -3.66%), beat estimates; EPS was 1.57 (YoY +11.35%), beat estimates.

Revenue / YoY

2.00B

-3.66%

EPS / YoY

1.57

+11.35%

Report date

Feb 26, 2026

SOLV Earnings Call Summary for Q4,2025

Revenue Growth: 3.5% 2025 organic growth, guided to 2-3% in 2026, driven by MedSurg (Acera integration), Dental (new products), and HIS (autonomous coding).
Margin Expansion: 21-21.5% 2026 operating margin target (vs. 20.5% in 2025), supported by $500M Transform for the Future savings.
Share Buyback: $1B program launched in Q1 2026 to offset dilution.
Tariff Risk: $100M-$120M 2026 impact, partially offset by SKU rationalization.
Long-Range Plan: On track for 4-5% revenue growth, 23-25% margins, and 10% EPS CAGR by 2028.

Earnings

EPS

Revenue

Revenue & Expenses

SOLV has released its 2025 Q4 earnings report, with revenue of 2.00B, reflecting a YoY change of -3.66%, and net profit of 63.00M, showing a YoY change of 110.00%. The Sankey diagram below clearly presents SOLV's revenue sources and cost distribution.

Key Indicators

Solventum (SOLV) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

Solventum (SOLV)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.

Trend

Breakdown

Balance Sheet

Solventum (SOLV)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.

Trend

Breakdown

Cash Flow

Solventum (SOLV)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.

Trend

Breakdown